Great Bay Bio Adds Two Industry Leaders to Advisory Board
Summary
HONG KONG--(BUSINESS WIRE)--Great Bay Bio, a leading AI biotechnology company dedicated to big data-driven CMC (Chemistry Manufacturing and Controls) development of innovative biologics, is pleased to announce the establishment of its 3D Advisory Board. Currently, the company will form three separate sub-committees (Business, Science and Technology) to provide a solid foundation for Great Bay Bio’s mission and, ultimately reach the company’s vision of "Making Biologics Development Easy For Everyone". Dr. Su was responsible for formulating the development strategy and daily operation management of top research centers endorsed by different famous Pharmaceutical brands, working closely with the site leaders from various functions to drive business priorities. With her solid scientific research capacity, she led the local team to excel in the global effort on clinical candidate development in metabolic diseases, hemophilia, autoimmune and cancer immunotherapy. The CMC platform encompasses an area of over 3100 square meter, and has a whole set of advanced biopharmaceutical research and development hardware, with key equipment from world-class brands such as Sartorius, Bio-Rad, GE Healthcare, and Waters.